InMode Authorizes $638M Share Buyback Amid Strong Cash Flow
Event summary
- InMode's board approved a new share repurchase program for up to 10% of outstanding shares (~6.38M shares).
- The company repurchased $127.4M of shares in 2025 despite challenging macroeconomic conditions.
- InMode will fund repurchases with available cash, subject to market conditions and legal requirements.
- The program may be modified, suspended, or discontinued at the company's discretion.
The big picture
InMode's share repurchase program reflects confidence in its cash flow generation and current valuation, despite macroeconomic challenges. The move aligns with a broader trend among medical technology companies using buybacks to return value to shareholders. The scale of the program (~10% of outstanding shares) suggests a strategic bet on undervaluation, but execution will depend on navigating regional conflicts and market volatility.
What we're watching
- Capital Allocation Strategy
- How InMode balances share buybacks with other capital allocation opportunities amid regional conflicts.
- Market Conditions
- Whether the company can sustain share repurchases given volatile market conditions.
- Execution Risk
- The pace at which InMode can execute the buyback program while maintaining operational discipline.